Bench-to-bedside review: Contrast enhanced ultrasonography - a promising technique to assess renal perfusion in the ICU

Critical Care

Volumn 15, Issue 3, 2011, Pages

  Schneider, Antoine ^a,b   Johnson, Lynne ^a   Goodwin, Mark ^a   Schelleman, Anthony ^a   Bellomo, Rinaldo ^a,b  

^a AUSTIN HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANGIOTENSIN II; CONTRAST MEDIUM; PERFLUBUTANE; PERFLUTREN; SONOVUE; VALSARTAN; DIAGNOSTIC AGENT;

ACUTE KIDNEY FAILURE; ALLERGY; BACKACHE; BLOODSTREAM INFECTION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; DIZZINESS; DYSPNEA; ECHOGRAPHY; EMBOLISM; FATIGUE; HEADACHE; HEART PALPITATION; HUMAN; HYPERSENSITIVITY; IMAGING SYSTEM; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY BLOOD FLOW; KIDNEY PERFUSION; MICROBUBBLE; NAUSEA; NONHUMAN; ODOR; POSITRON EMISSION TOMOGRAPHY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PRURITUS; RASH; REVIEW; RISK ASSESSMENT; SIDE EFFECT; TASTE; THORAX PAIN; URTICARIA; XEROSTOMIA; ANIMAL; HOSPITAL INFORMATION SYSTEM; KIDNEY; PATHOPHYSIOLOGY; VASCULARIZATION;

ACUTE KIDNEY INJURY; ANIMALS; CONTRAST MEDIA; HUMANS; INTENSIVE CARE UNITS; KIDNEY; MICROBUBBLES; POINT-OF-CARE SYSTEMS;

EID: 84856875334     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10058     Document Type: Review

References (41)

1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, . Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818. 10.1001/jama.294.7.813, 16106006, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.
2. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996, 275:1489-1494. 10.1001/jama.275.19.1489, 8622223.
3. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998, 104:343-348. 10.1016/S0002-9343(98)00058-8, 9576407.
4. Prowle JR, Ishikawa K, May CN, Bellomo R. Renal blood flow during acute renal failure in man. Blood Purif 2009, 28:216-225. 10.1159/000230813, 19648741.
5. Selkurt EE. Renal blood flow and renal clearance in hemorraghic shock. Am J Physiol 1946, 145:699-799.
6. Wan L, Yang N, Hiew CY, Schelleman A, Johnson L, May C, Bellomo R. An assessment of the accuracy of renal blood flow estimation by Doppler ultrasound. Intensive Care Med 2008, 34:1503-1510. 10.1007/s00134-008-1106-8, 18408915.
7. Hofmann L, Simon-Zoula S, Nowak A, Giger A, Vock P, Boesch C, Frey FJ, Vogt B. BOLD-MRI for the assessment of renal oxygenation in humans: acute effect of nephrotoxic xenobiotics. Kidney Int 2006, 70:144-150. 10.1038/sj.ki.5000418, 16641929.
8. Prowle JR, Molan MP, Hornsey E, Bellomo R. Cine phase-contrast magnetic resonance imaging for the measurement of renal blood flow. Contrib Nephrol 2010, 165:329-336.
9. Geleskie JV, Shung KK. Further studies on acoustic impedance of major bovine blood vessel walls. J Acoust Soc Am 1982, 71:467-470. 10.1121/1.387417, 7069062.
10. Ophir J, Parker KJ. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 1989, 15:319-333. 10.1016/0301-5629(89)90044-6, 2669297.
11. Schacherer D, Klebl F, Goetz D, Buettner R, Zierhut S, Schoelmerich J, Langgartner J. Abdominal ultrasound in the intensive care unit: a 3-year survey on 400 patients. Intensive Care Med 2007, 33:841-844. 10.1007/s00134-007-0577-3, 17364166.
12. de Jong N, Ten Cate FJ, Lancee CT, Roelandt JR, Bom N. Principles and recent developments in ultrasound contrast agents. Ultrasonics 1991, 29:324-330. 10.1016/0041-624X(91)90030-C, 2058051.
13. Raisinghani A, Rafter P, Phillips P, Vannan MA, DeMaria AN. Microbubble contrast agents for echocardiography: rationale, composition, ultrasound interactions, and safety. Cardiol Clin 2004, 22:171-180. v, 10.1016/j.ccl.2004.02.001, 15158932.
14. Romero JR, Frey JL, Schwamm LH, Demaerschalk BM, Chaliki HP, Parikh G, Burke RF, Babikian VL. Cerebral ischemic events associated with 'bubble study' for identification of right to left shunts. Stroke 2009, 40:2343-2348. 10.1161/STROKEAHA.109.549683, 19498192.
15. Feinstein SB, Cheirif J, Ten Cate FJ, Silverman PR, Heidenreich PA, Dick C, Desir RM, Armstrong WF, Quinones MA, Shah PM. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. J Am Coll Cardiol 1990, 16:316-324. 10.1016/0735-1097(90)90580-I, 2197312.
16. Klibanov A. Ultrasound contrast agents: development of the field and current status. Topics Curr Chem 2002, 222:73-106.
17. Morel DR, Schwieger I, Hohn L, Terrettaz J, Llull JB, Cornioley YA, Schneider M. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 2000, 35:80-85. 10.1097/00004424-200001000-00009, 10639039.
18. Cosgrove D. Angiogenesis imaging - ultrasound. Br J Radiol 2003, 76(Spec No 1):S43-49.
19. Schneider M. Bubbles and microcirculatory disorders. Eur Radiol 2001, 11(Suppl 3):E1-5.
20. Mulvagh SL, Rakowski H, Vannan MA, Abdelmoneim SS, Becher H, Bierig SM, Burns PN, Castello R, Coon PD, Hagen ME, Jollis JG, Kimball TR, Kitzman DW, Kronzon I, Labovitz AJ, Lang RM, Mathew J, Moir WS, Nagueh SF, Pearlman AS, Perez JE, Porter TR, Rosenbloom J, Strachan GM, Thanigaraj S, Wei K, Woo A, Yu EH, Zoghbi WA, . American Society of Echocardiography American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography. J Am Soc Echocardiogr 2008, 21:1179-1201. quiz 1281, 10.1016/j.echo.2008.09.009, 18992671, American Society of Echocardiography.
21. Fisher NG, Christiansen JP, Leong-Poi H, Jayaweera AR, Lindner JR, Kaul S. Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent. J Am Coll Cardiol 2002, 39:530-537. 10.1016/S0735-1097(01)01759-4, 11823094.
22. Lindner JR, Song J, Jayaweera AR, Sklenar J, Kaul S. Microvascular rheology of DeFinity microbubbles after intra-arterial and intravenous administration. J Am Soc Echocardiogr 2002, 15:396-403. 10.1067/mje.2002.117290, 12019422.
23. Braide M, Rasmussen H, Albrektsson A, Bagge U. Microvascular behavior and effects of sonazoid microbubbles in the cremaster muscle of rats after local administration. J Ultrasound Med 2006, 25:883-890.
24. Kusnetzky LL, Khalid A, Khumri TM, Moe TG, Jones PG, Main ML. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 consecutive studies. J Am Coll Cardiol 2008, 51:1704-1706. 10.1016/j.jacc.2008.03.006, 18436124.
25. Dolan MS, Gala SS, Dodla S, Abdelmoneim SS, Xie F, Cloutier D, Bierig M, Mulvagh SL, Porter TR, Labovitz AJ. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience. J Am Coll Cardiol 2009, 53:32-38. 10.1016/j.jacc.2008.08.066, 19118722.
26. Main ML, Ryan AC, Davis TE, Albano MP, Kusnetzky LL, Hibberd M. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients). Am J Cardiol 2008, 102:1742-1746. 10.1016/j.amjcard.2008.08.019, 19064035.
27. Wei K, Mulvagh SL, Carson L, Davidoff R, Gabriel R, Grimm RA, Wilson S, Fane L, Herzog CA, Zoghbi WA, Taylor R, Farrar M, Chaudhry FA, Porter TR, Irani W, Lang RM. The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr 2008, 21:1202-1206. 10.1016/j.echo.2008.07.019, 18848430.
28. Jiménez C, de Gracia R, Aguilera A, Alonso S, Cirugeda A, Benito J, Regojo RM, Aguilar R, Warlters A, Gómez R, Largo C, Selgas R. In situ kidney insonation with microbubble contrast agents does not cause renal tissue damage in a porcine model. J Ultrasound Med 2008, 27:1607-1615.
29. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998, 97:473-483.
30. Wei K, Le E, Bin JP, Coggins M, Thorpe J, Kaul S. Quantification of renal blood flow with contrast-enhanced ultrasound. J Am Coll Cardiol 2001, 37:1135-1140. 10.1016/S0735-1097(00)01210-9, 11263620.
31. Tiemann K, Becher H, Lohmeier S. Real-time assessment of tissue perfusion following bubble destruction at low emission-power - first experimental results using power pulse inversion imaging. J Am Coll Cardiol 2000, 35:426A.
32. Arditi M, Frinking PJ, Zhou X, Rognin NG. A new formalism for the quantification of tissue perfusion by the destruction-replenishment method in contrast ultrasound imaging. IEEE Trans Ultrason Ferroelectr Freq Control 2006, 53:1118-1129.
33. Rim SJ, Leong-Poi H, Lindner JR, Couture D, Ellegala D, Mason H, Durieux M, Kassel NF, Kaul S. Quantification of cerebral perfusion with "real-time" contrast-enhanced ultrasound. Circulation 2001, 104:2582-2587. 10.1161/hc4601.099400, 11714654.
34. Vogel R, Indermuhle A, Reinhardt J, Meier P, Siegrist PT, Namdar M, Kaufmann PA, Seiler C. The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. J Am Coll Cardiol 2005, 45:754-762. 10.1016/j.jacc.2004.11.044, 15734622.
35. Kishimoto N, Mori Y, Nishiue T, Shibasaki Y, Iba O, Nose A, Uchiyama-Tanaka Y, Masaki H, Matsubara H, Iwasaka T. Renal blood flow measurement with contrast-enhanced harmonic ultrasonography: evaluation of dopamine-induced changes in renal cortical perfusion in humans. Clin Nephrol 2003, 59:423-428.
36. Kishimoto N, Mori Y, Nishiue T, Nose A, Kijima Y, Tokoro T, Yamahara H, Okigaki M, Kosaki A, Iwasaka T. Ultrasound evaluation of valsartan therapy for renal cortical perfusion. Hypertens Res 2004, 27:345-349. 10.1291/hypres.27.345, 15198482.
37. Kalantarinia K, Belcik JT, Patrie JT, Wei K. Real-time measurement of renal blood flow in healthy subjects using contrast-enhanced ultrasound. Am J Physiol Renal Physiol 2009, 297:F1129-1134. 10.1152/ajprenal.00172.2009, 2775574, 19625375.
38. Schneider A, Eggimann P, Burnier M, Vogt B. Renal perfusion quantification with contrast echography [abstract]. Swiss Med Forum 2009, 9(Suppl 48):7S.
39. Fischer T, Dieckhofer J, Muhler M, Lembcke A, Morgera S, Budde K, Neumayer HH, Ebeling V, Thomas A, Filimonow S. The use of contrast-enhanced US in renal transplant: first results and potential clinical benefi t. Eur Radiol 2005, 15(Suppl 5):E109-116.
40. Schwenger V, Korosoglou G, Hinkel UP, Morath C, Hansen A, Sommerer C, Dikow R, Hardt S, Schmidt J, Kücherer H, Katus HA, Zeier M. Real-time contrast-enhanced sonography of renal transplant recipients predicts chronic allograft nephropathy. Am J Transplant 2006, 6:609-615. 10.1111/j.1600-6143.2005.01224.x, 16468973.
41. Benozzi L, Cappelli G, Granito M, Davoli D, Favali D, Montecchi MG, Grossi A, Torricelli P, Albertazzi A. Contrast-enhanced sonography in early kidney graft dysfunction. Transplant Proc 2009, 41:1214-1215. 10.1016/j.transproceed.2009.03.029, 19460520.